REATA PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)

Published: 2021-10-22 06:08:07 ET RETA

Ms. Elaine Castellanos, Senior Vice President, Chief Accounting Officer, has informed us of her intention to retire and submitted her resignation on October 18, 2021, effective as of November 12, 2021. Ms. Castellanos will provide consulting services to us for up to one year at an hourly rate.

Mr. Bhaskar Anand, currently Vice President, Accounting of the Company, has been appointed as Vice President, Chief Accounting Officer of the Company effective as of November 13, 2021. Mr. Anand will report to the Company's Chief Operating Officer and Chief Financial Officer, Manmeet S. Soni. In his new position, Mr. Anand will oversee the Company's financial accounting and reporting.

Mr. Anand, age 44, has served as the Company's Vice President, Accounting since July 2021. Prior to that time, Mr. Anand served at JUUL Labs as Corporate Controller from September 2020 to May 2021, having responsibility for global accounting and taxation functions, and as Global Revenue Controller and Head of Technical Accounting from August 2018 to August 2020, having responsibility for global revenue operations and technical accounting functions. Prior to that time, Mr. Anand served at Oracle Corporation as Director of Technical Accounting and SEC Reporting from August 2016 to July 2018, having responsibility for technical accounting, SEC reporting, and finance lead for Merger & Acquisitions. Prior to serving at Oracle, Mr. Anand was Senior Manager, Assurance, at PricewaterhouseCoopers, having responsibility for providing assurance services to various public and privately held multinationals across various industries.

--------------------------------------------------------------------------------